In recent years, a large number of studies have shown that PHB1 expression is upregulated in a variety of human malignancies, including lung cancer, diffuse large B-cell lymphomas (DLBCL), cervical cancer, bladder cancer, glioblastoma, endometrial cancer, and breast cancer, etc. [22–27]. This evidence concerns the gene PHB1 and breast carcinoma.